Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – The Role of Patient-Reported Outcome Measures in the Continuum of Cancer Clinical Care

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

Ann Oncol. 2022
M. Di Maio, E. Basch, F. Denis et al, on behalf of the ESMO Guidelines Committee

  • This ESMO Guideline provides key recommendations on the role of PROMs during the care of patients with cancer.
  • It covers the use of PROMs in patients with cancer from the start of active treatment during follow-up and at the end of life.
  • Recommendations are based on available scientific evidence and the authors’ collective expert consensus.
  • Authorship includes a multidisciplinary group of experts from Europe, North America, Asia & Australia.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.